🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, placebo-controlled, single ascending dose st...
Status
Completed
Location
Changi General Hospital; Clinical Trial & Research unit
Start Date
2013-12
Trial ID
NCT02015715
The purpose of this study is to assess the safety and tolerability of SF200...
Status
Unknown
Location
Tropical Diseases Resaerch Centre
Start Date
2016-09
Trial ID
NCT02941159
This is a Phase 1, two-part, randomized, double blind, placebo controlled, ...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2022-06-07
Trial ID
NCT05364840
SRT2104 is a potent small molecule activator of SIRT1 that has been found t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-09
Trial ID
NCT01014117
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i....
Status
Active Not Recruiting
Location
UAB Childrens Hospital Harbor Center Neurology Dept
Start Date
2013-07-26
Trial ID
NCT01892722
Treatments Being Tested
Sepsis is a life-threatening condition that occurs when the body's response...
Status
Not Yet Recruiting
Location
Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde"
Start Date
2026-03-01
Trial ID
NCT07436130
The purpose of this study is to assess the safety and tolerability of TMC64...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01202825
The general aim of the current study was to investigate the safety and tole...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT02224105
The purpose of this study is to investigate clinical efficacy and safety of...
Status
Completed
Location
Sanglah Hospital Denpasar
Start Date
2009-10
Trial ID
NCT01005069
Treatments Being Tested
Neurofibromatosis type I (NF1) is a genetic disorder that affects approxima...
Status
Completed
Location
Semel Institute for Neuroscience and Human Behavior
Start Date
2009-09
Trial ID
NCT00352599
Treatments Being Tested